Open AccessAdding prostate-specific membrane antigen positron emission tomography (PSMA PET) to our prostate cancer armamentarium raises many questions
Author(s) -
Laurence Klotz
Publication year - 2021
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.7336
Subject(s) - prostate cancer , glutamate carboxypeptidase ii , positron emission tomography , medicine , prostate , cancer , nuclear medicine , oncology